Warburg, B Capital, Qiming, Others Invest USD60m Series D for Hong Kong’s Insilico
Source(s): Insilico
Insilico, a Hong Kong-based drug discovery company, raised a USD60m Series D from Warburg Pincus, B Capital Group, Qiming Venture Partners, Bold Capital Partners and Pavilion Capital. Read more